Spring direct naar de hoofdnavigatie of de inhoud

Frits Michiels

Patent attorney

“To explore, together with a client, how the best IP protection can be obtained is for me the logical next step after an invention has been made.”
Home / Experts / Frits Michiels

Frits Michiels

Frits Michiels

  • Life Sciences
  • European Patent Attorney
  • Dutch Patent Attorney
  • Senior Associate

Frits Michiels has had an extensive scientific career in both knowledge institutes and biotech companies. From 2004, he was employed as IP manager at Galapagos Genomics BV and subsequently also at other Dutch biotech startups, such as Agendia and Merus. He has worked for V.O. since 2006.

More information about Frits

He is specialized in biochemistry, molecular biology, cell biology, diagnostics, signal transduction, and medical biotechnology. His clients are primarily knowledge institutes and start ups. He is involved in patent prosecution and strategic advice.

Working experience

  • Patent Attorney, V.O. (2006-present)
  • Merus (2006)
  • Galapagos Genomics (1999-2005)
  • Senior Scientist at the Netherlands Cancer Institute (1994-1998)
  • Post-Doc, Amsterdam Medical Center (1991-1993)
  • PhD research at Max Planck Institute for Biochemistry, Munich (1985-1990)

Education

  • PhD in Genetics, Radboud University Nijmegen (1990)
  • MSc in Microbiology, Radboud University Nijmegen (1984)

Publications

  • Michiels, GAM Damages extended to after termination of a tort. MIP Vol 205: 94-95 (2011)
  • JP ten Klooster, EE Evers, L Janssen, LM Machesky, F Michiels, P Hordijk and JG Collard. Biochem J. 397, 39–45 (2006)
  • GJ Arts, E Langemeijer, R Tissingh, L Ma, H Pavliska, K Dokic, R Dooijes, E Mesić, R Clasen, F Michiels, J van der Schueren, M Lambrecht, S Herman, R Brys, K Thys, M Hoffmann, P Tomme, H van Es. Genome Res 13, 2325-32 (2003)
  • A Malliri, RA van der Kammen, K Clark, M van der Valk, F Michiels & JG Collard. Nature 417, 867-871 (2002)
  • F Michiels et al. Nature Biotech 20, 1154-1157 (2002)
  • R Engers, E Springer, F Michiels, JG Collard, HE Gabbert. J Biol Chem 276, 41889-97 (2001)
  • WO2002057463 Swap/counter selection; a rapid cloning
  • WO2002070744 Adenoviral library assay for E2F regulatory genes and methods and compositions for screening compounds method
  • WO2005124342 Methods and means for treatment of osteoarthritis

Languages

  • English
  • Dutch
  • German

Also see these experts

Mark Einerhand

Mark Einerhand

  • European Patent Attorney
  • Dutch Patent Attorney
  • Partner
Jetze Beeksma

Jetze Beeksma

  • European Patent Attorney
  • Dutch Patent Attorney
  • Associate
More experts

News

HEMA faces claim by Levi’s over stitching

Denim giant Levi’s recently won a court case in Belgium against the well-known department store HEMA about the shape of the stitches on the rear of its jeans.Continue reading

Brexit

The impact of Brexit on IP rights

The United Kingdom (UK) is expected to leave the European Union on 29 March 2019, with or without a deal. The British Parliament has expressly stated that the existing IP rights that have been established within the EU context will be guaranteed in either case. Below you will find a brief overview of the impact […]Continue reading

Supplier must warn of potential patent infringement in another country

Imagine that you sell a product that does not fall under the Netherlands’ patent protection to a customer, but your customer then exports the product to Germany where it is protected by a patent. How does this affect your liability?Continue reading

Events

NCCC Conference 2019

Hotel NH Noordwijk Conference Centre Leeuwenhorst, Langelaan, Noordwijkerhout

The 20th Netherlands Catalysis and Chemistry Conference will take place March 4-6, 2019 in Noordwijkerhout, The Netherlands. More about this event

Idea, IP & Innovation (3i-) Event

High Tech Campus Eindhoven, High Tech Campus, Eindhoven

On Tuesday 18 April TW.nl organizes the second edition of the 3i-Event. During this inspiring afternoon about Ideas, Intellectual property and Innovation on the Hightech Campus in Eindhoven, R&D professionals, startups and SME entrepreneurs will learn how to set up a successful IP strategy for their companies. More about this event

Knowledge for Growth 2019

Gent ICC, Gent, België

Don’t miss the 2019 edition on 9 May  and capture the attention of 1,200 high-level life sciences actors from about 550 companies & organisations! The cream of the European life sciences community will be attending the 15th edition of flanders.bio’s annual knowledge for growth business conference, attracting decision makers from biotech, pharma and medtech as well as investors, universities, topnotch research institutes, policymakers and competence providers. More about this event